Behçet: the syndrome
Authors:
- 29 April 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 59 (Supplement) , iii101-iii107
Abstract
Behçet’s syndrome (BS) is a systemic vasculitis characterized by a relapsing and remitting course. It can involve the skin, mucosa, joints, vessels (arteries and/or veins), eyes, and nervous and gastrointestinal systems, and so is referred to as a syndrome rather than as a unique and nosologically distinct condition. These involvements may present alone or co-exist in the same patient. Although all the possible combinations of the above-mentioned manifestations may occur, clusters of commonly co-existing involvements (also referred to as ‘disease phenotypes’) have been suggested, namely ‘mucocutaneous and articular’, ‘peripheral vascular and extra-parenchymal neurological’ and ‘parenchymal neurological and ocular’ phenotypes have been described. Patient-specific demographic and genetic features have been described as positively or negatively associated with specific disease phenotypes. This review will focus on the different clinical features of Behçet’s syndrome, summarizing current evidence on the distinct disease manifestations as well as the major phenotypes.Keywords
Funding Information
- University of Cambridge
This publication has 53 references indexed in Scilit:
- Phenotypes in Behçet’s syndromeInternal and Emergency Medicine, 2019
- Behçet syndrome: a contemporary viewNature Reviews Rheumatology, 2018
- Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective studyInternal and Emergency Medicine, 2017
- Dietary and Nondietary Triggers of Oral Ulcer Recurrences in Behçet's DiseaseArthritis Care & Research, 2016
- Behçet's disease: A comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesionsThe Journal of Dermatology, 2016
- Mucocutaneous Involvement in Behçet’s Disease: How Systemic Treatment Has Changed in the Last Decades and Future PerspectivesMediators of Inflammation, 2015
- The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteriaJournal of the European Academy of Dermatology and Venereology, 2013
- Behçet Syndrome: Is It One Condition?Clinical Reviews in Allergy & Immunology, 2012
- The Long-Term Mortality and Morbidity of Behçet SyndromeMedicine, 2003
- Behçet’s disease, the Silk Road and HLA‐B51: historical and geographical perspectivesTissue Antigens, 1999